Skip to main content
. 2020 Aug 18;4(16):3864–3874. doi: 10.1182/bloodadvances.2020001904

Figure 1.

Figure 1.

Prognostic impact of the ELN2017 risk classification in patients with AML who undergo allogeneic HSCT. Allocation to the 3 risk groups according to the ELN2017 classification predicted CIR (A) and OS (B) in patients with AML who undergo allogeneic HSCT. The prognostic impact, CIR (C) and OS (D) was retained in patients who underwent allogeneic HSCT after NMA conditioning.